{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:02:08Z","timestamp":1778817728390,"version":"3.51.4"},"reference-count":92,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"vor","delay-in-days":1296,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1111\/ajt.15292","type":"journal-article","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T09:42:48Z","timestamp":1549446168000},"page":"1266-1277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Gynecologic cancers and solid organ transplantation"],"prefix":"10.1016","volume":"19","author":[{"given":"John B.","family":"Liao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia E.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret M.","family":"Madeleine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1111\/ajt.15292_bib1","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA."},{"issue":"9581","key":"10.1111\/ajt.15292_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet."},{"issue":"2 suppl","key":"10.1111\/ajt.15292_bib3","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1097\/01.tp.0000186382.81130.ba","article-title":"Malignancy after transplantation","volume":"80","author":"Buell","year":"2005","journal-title":"Transplantation."},{"issue":"9","key":"10.1111\/ajt.15292_bib4","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1111\/j.1600-6143.2007.01908.x","article-title":"Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15 183 recipients","volume":"7","author":"Webster","year":"2007","journal-title":"Am J Transplant."},{"issue":"2","key":"10.1111\/ajt.15292_bib5","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/JME-14-0252","article-title":"Progesterone action in breast, uterine, and ovarian cancers","volume":"54","author":"Diep","year":"2015","journal-title":"J Mol Endocrinol."},{"issue":"12","key":"10.1111\/ajt.15292_bib6","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1111\/ajt.12472","article-title":"HPV-related cancers after solid organ transplantation in the United States","volume":"13","author":"Madeleine","year":"2013","journal-title":"Am J Transplant."},{"issue":"7","key":"10.1111\/ajt.15292_bib7","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/sj.bjc.6601219","article-title":"Cancer risk following organ transplantation: a nationwide cohort study in Sweden","volume":"89","author":"Adami","year":"2003","journal-title":"Br J Cancer."},{"issue":"23","key":"10.1111\/ajt.15292_bib8","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1001\/jama.296.23.2823","article-title":"Cancer incidence before and after kidney transplantation","volume":"296","author":"Vajdic","year":"2006","journal-title":"JAMA."},{"issue":"4","key":"10.1111\/ajt.15292_bib9","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1600-6143.2007.01736.x","article-title":"Cancer incidence among Canadian kidney transplant recipients","volume":"7","author":"Villeneuve","year":"2007","journal-title":"Am J Transplant."},{"issue":"14","key":"10.1111\/ajt.15292_bib10","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.ejca.2007.07.015","article-title":"Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe","volume":"43","author":"Serraino","year":"2007","journal-title":"Eur J Cancer."},{"issue":"6","key":"10.1111\/ajt.15292_bib11","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1600-6143.2004.00450.x","article-title":"Cancer after kidney transplantation in the United States","volume":"4","author":"Kasiske","year":"2004","journal-title":"Am J Transplant."},{"issue":"8","key":"10.1111\/ajt.15292_bib12","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1111\/j.1600-6143.2010.03181.x","article-title":"Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit","volume":"10","author":"Collett","year":"2010","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15292_bib13","series-title":"GLOBOCAN 2012 v1. 0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11","author":"Ferlay","year":"2013"},{"issue":"4","key":"10.1111\/ajt.15292_bib14","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study","volume":"3","author":"Fitzmaurice","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1111\/ajt.15292_bib15","unstructured":"National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program - SEER*Stat Database: Incidence - SEER 13 Regs Research Data, Nov 2014 Sub (1992-2012) <Katrina\/Rita Population Adjustment> - Linked To County Attributes - Total U.S., 1969-2013 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2015, based on the November 2014 submission. 2015; http:\/\/seer.cancer.gov\/data\/seerstat\/nov2014\/. Accessed April 21, 2018."},{"key":"10.1111\/ajt.15292_bib16","doi-asserted-by":"crossref","first-page":"16086","DOI":"10.1038\/nrdp.2016.86","article-title":"Carcinogenic human papillomavirus infection","volume":"2","author":"Schiffman","year":"2016","journal-title":"Nat Rev Dis Primers."},{"issue":"6","key":"10.1111\/ajt.15292_bib17","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/ijc.27765","article-title":"Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008\u2013a Swedish population-based study","volume":"132","author":"Krynitz","year":"2013","journal-title":"Int J Cancer."},{"issue":"5","key":"10.1111\/ajt.15292_bib18","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/ijc.30531","article-title":"Cancer risks after solid organ transplantation and after long-term dialysis","volume":"140","author":"Hortlund","year":"2017","journal-title":"Int J Cancer."},{"issue":"9","key":"10.1111\/ajt.15292_bib19","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1111\/ajt.14272","article-title":"Uptake of cancer screening tests among recipients of solid organ transplantation","volume":"17","author":"Acuna","year":"2017","journal-title":"Am J Transplant."},{"issue":"7","key":"10.1111\/ajt.15292_bib20","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.healun.2003.07.018","article-title":"Sexual health issues after lung transplantation: importance of cervical screening","volume":"23","author":"Malouf","year":"2004","journal-title":"J Heart Lung Transplant."},{"issue":"9173","key":"10.1111\/ajt.15292_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(99)06154-1","article-title":"Cancer in patients on dialysis for end-stage renal disease: an international collaborative study","volume":"354","author":"Maisonneuve","year":"1999","journal-title":"Lancet."},{"issue":"1","key":"10.1111\/ajt.15292_bib22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/ndt\/gfv444","article-title":"Immunogenicity and safety of quadrivalent human papillomavirus types 6\/11\/16\/18 recombinant vaccine in chronic kidney disease stage IV, V and VD","volume":"32","author":"Praditpornsilpa","year":"2017","journal-title":"Nephrol Dial Transplant."},{"issue":"1","key":"10.1111\/ajt.15292_bib23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00004347-198803000-00004","article-title":"Human papillomavirus type 16 in multifocal neoplasia of the female genital tract","volume":"7","author":"Beckmann","year":"1988","journal-title":"Int J Gynecol Pathol."},{"issue":"7629","key":"10.1111\/ajt.15292_bib24","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1136\/bmj.39363.471806.BE","article-title":"Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study","volume":"335","author":"Strander","year":"2007","journal-title":"BMJ."},{"issue":"10","key":"10.1111\/ajt.15292_bib25","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1111\/ajt.14289","article-title":"Incidence and predictors of cancer following kidney transplantation in childhood","volume":"17","author":"Francis","year":"2017","journal-title":"Am J Transplant."},{"issue":"1","key":"10.1111\/ajt.15292_bib26","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1600-6143.2010.03367.x","article-title":"Pediatric organ transplantation and risk of premalignant and malignant tumors in Sweden","volume":"11","author":"Simard","year":"2011","journal-title":"Am J Transplant."},{"issue":"5","key":"10.1111\/ajt.15292_bib27","doi-asserted-by":"crossref","first-page":"e20163893","DOI":"10.1542\/peds.2016-3893","article-title":"Cancer risk after pediatric solid organ transplantation","volume":"139","author":"Yanik","year":"2017","journal-title":"Pediatrics."},{"issue":"1","key":"10.1111\/ajt.15292_bib28","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin."},{"key":"10.1111\/ajt.15292_bib29","unstructured":"Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2014, National Cancer Institute. Bethesda, MD, https:\/\/seer.cancer.gov\/csr\/1975_2014\/. Accessed on May 6, 2018."},{"key":"10.1111\/ajt.15292_bib30","first-page":"197","article-title":"Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products","volume":"12","author":"M\u00fcnger","year":"1992","journal-title":"Cancer Surv."},{"issue":"4","key":"10.1111\/ajt.15292_bib31","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"de Martel","year":"2017","journal-title":"Int J Cancer."},{"issue":"9","key":"10.1111\/ajt.15292_bib32","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/TP.0b013e318249b13d","article-title":"Anogenital malignancies in women after renal transplantation over 40 years in a single center","volume":"93","author":"Meeuwis","year":"2012","journal-title":"Transplantation."},{"issue":"2","key":"10.1111\/ajt.15292_bib33","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1086\/426867","article-title":"A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women","volume":"191","author":"Brown","year":"2005","journal-title":"J Infect Dis."},{"key":"10.1111\/ajt.15292_bib34","series-title":"Principles and Practice of Gynecologic Oncology","author":"Chi","year":"2017"},{"issue":"1","key":"10.1111\/ajt.15292_bib35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.trre.2017.10.002","article-title":"Cancer evaluation in the assessment of solid organ transplant candidates: a systematic review of clinical practice guidelines","volume":"32","author":"Acuna","year":"2018","journal-title":"Transplant Rev (Orlando)."},{"issue":"9103","key":"10.1111\/ajt.15292_bib36","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(97)08496-1","article-title":"Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens","volume":"351","author":"Dantal","year":"1998","journal-title":"Lancet."},{"key":"10.1111\/ajt.15292_bib37","doi-asserted-by":"crossref","first-page":"g6679","DOI":"10.1136\/bmj.g6679","article-title":"Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data","volume":"349","author":"Knoll","year":"2014","journal-title":"BMJ."},{"issue":"2","key":"10.1111\/ajt.15292_bib38","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/ajt.13596","article-title":"Immunosuppressive medications and squamous cell skin carcinoma: nested case-control study within the skin cancer after organ transplant (SCOT) cohort","volume":"16","author":"Coghill","year":"2016","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15292_bib39","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2407-5-4","article-title":"Mycophenolate mofetil modulates adhesion receptors of the beta1 integrin family on tumor cells: impact on tumor recurrence and malignancy","volume":"5","author":"Engl","year":"2005","journal-title":"BMC Cancer."},{"issue":"8","key":"10.1111\/ajt.15292_bib40","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1200\/JCO.2014.58.3401","article-title":"Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma","volume":"33","author":"Slomovitz","year":"2015","journal-title":"J Clin Oncol."},{"issue":"1","key":"10.1111\/ajt.15292_bib41","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ygyno.2012.12.022","article-title":"Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study","volume":"129","author":"Alvarez","year":"2013","journal-title":"Gynecol Oncol."},{"issue":"1","key":"10.1111\/ajt.15292_bib42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ygyno.2011.06.022","article-title":"Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: a Gynecologic Oncology Group study","volume":"123","author":"Behbakht","year":"2011","journal-title":"Gynecol Oncol."},{"issue":"suppl 1","key":"10.1111\/ajt.15292_bib43","first-page":"S105","article-title":"Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer","volume":"95","author":"Creasman","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"issue":"22","key":"10.1111\/ajt.15292_bib44","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/jnci\/dji378","article-title":"Impact of hysterectomy on endometrial carcinoma rates in the United States","volume":"97","author":"Sherman","year":"2005","journal-title":"J Natl Cancer Inst."},{"issue":"12","key":"10.1111\/ajt.15292_bib45","first-page":"1639","article-title":"Long-term use of continuous-combined estrogen-progestin hormone therapy and risk of endometrial cancer","volume":"22","author":"Phipps","year":"2011","journal-title":"Cancer Causes Control."},{"issue":"20","key":"10.1111\/ajt.15292_bib46","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","article-title":"Type I and II endometrial cancers: have they different risk factors?","volume":"31","author":"Setiawan","year":"2013","journal-title":"J Clin Oncol."},{"issue":"3","key":"10.1111\/ajt.15292_bib47","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/bjc.2013.2","article-title":"The etiology of uterine sarcomas: a pooled analysis of the epidemiology of endometrial cancer consortium","volume":"108","author":"Felix","year":"2013","journal-title":"Br J Cancer."},{"issue":"2","key":"10.1111\/ajt.15292_bib48","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1525-1438.2007.01025.x","article-title":"The risk of developing uterine sarcoma after tamoxifen use","volume":"18","author":"Lavie","year":"2008","journal-title":"Int J Gynecol Cancer."},{"issue":"1","key":"10.1111\/ajt.15292_bib49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1158\/0008-5472.CAN-15-1382","article-title":"It\u2019s totally tubular\u2026.riding the new wave of ovarian cancer research","volume":"76","author":"Perets","year":"2016","journal-title":"Cancer Res."},{"issue":"2","key":"10.1111\/ajt.15292_bib50","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ygyno.2005.02.007","article-title":"Ovarian cancer incidence in the United States, 1992-1999","volume":"97","author":"Quirk","year":"2005","journal-title":"Gynecol Oncol."},{"issue":"5","key":"10.1111\/ajt.15292_bib51","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/01.AOG.0000216004.22588.ce","article-title":"Incidence and survival rates for female malignant germ cell tumors","volume":"107","author":"Smith","year":"2006","journal-title":"Obstet Gynecol."},{"issue":"2","key":"10.1111\/ajt.15292_bib52","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ygyno.2009.06.040","article-title":"The epidemiology of ovarian granulosa cell tumors: a case-control study","volume":"115","author":"Boyce","year":"2009","journal-title":"Gynecol Oncol."},{"issue":"2","key":"10.1111\/ajt.15292_bib53","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ogc.2013.02.005","article-title":"Cervical cancer screening in immunocompromised women","volume":"40","author":"Nguyen","year":"2013","journal-title":"Obstet Gynecol Clin North Am."},{"issue":"1","key":"10.1111\/ajt.15292_bib54","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/ajt.13978","article-title":"Cancer screening recommendations for solid organ transplant recipients: a systematic review of clinical practice guidelines","volume":"17","author":"Acuna","year":"2017","journal-title":"Am J Transplant."},{"issue":"7","key":"10.1111\/ajt.15292_bib55","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1097\/TP.0b013e31819d32eb","article-title":"The health and economic impact of cervical cancer screening and human papillomavirus vaccination in kidney transplant recipients","volume":"87","author":"Wong","year":"2009","journal-title":"Transplantation."},{"issue":"4","key":"10.1111\/ajt.15292_bib56","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/ajt.14507","article-title":"Decreasing incidence of cancer after liver transplantation-A Nordic population-based study over 3 decades","volume":"18","author":"Nordin","year":"2018","journal-title":"Am J Transplant."},{"issue":"1","key":"10.1111\/ajt.15292_bib57","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1600-6143.2012.04302.x","article-title":"Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients","volume":"13","author":"Na","year":"2013","journal-title":"Am J Transplant."},{"issue":"1","key":"10.1111\/ajt.15292_bib58","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.hoc.2011.11.003","article-title":"Genetic risk and gynecologic cancers","volume":"26","author":"Holman","year":"2012","journal-title":"Hematol Oncol Clin North Am."},{"issue":"7","key":"10.1111\/ajt.15292_bib59","doi-asserted-by":"crossref","first-page":"a015677","DOI":"10.1101\/cshperspect.a015677","article-title":"Cancer in the transplant recipient","volume":"3","author":"Chapman","year":"2013","journal-title":"Cold Spring Harb Perspect Med."},{"issue":"Suppl 2","key":"10.1111\/ajt.15292_bib60","first-page":"3","article-title":"The evaluation of renal transplantation candidates: clinical practice guidelines","volume":"1","author":"Kasiske","year":"2001","journal-title":"Am J Transplant."},{"issue":"3","key":"10.1111\/ajt.15292_bib61","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/TP.0b013e31829854b7","article-title":"Overall and cause-specific mortality in transplant recipients with a pretransplantation cancer history","volume":"96","author":"Brattstr\u00f6m","year":"2013","journal-title":"Transplantation."},{"issue":"6","key":"10.1111\/ajt.15292_bib62","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ajog.2011.03.008","article-title":"Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations","volume":"204","author":"Salani","year":"2011","journal-title":"Am J Obstet Gynecol."},{"issue":"33","key":"10.1111\/ajt.15292_bib63","doi-asserted-by":"crossref","first-page":"874","DOI":"10.15585\/mmwr.mm6633a2","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2016","volume":"66","author":"Walker","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"49","key":"10.1111\/ajt.15292_bib64","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.15585\/mmwr.mm6549a5","article-title":"Use of a 2-dose schedule for human papillomavirus vaccination - updated recommendations of the advisory committee on immunization practices","volume":"65","author":"Meites","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"9","key":"10.1111\/ajt.15292_bib65","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1111\/ajt.12329","article-title":"Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients","volume":"13","author":"Kumar","year":"2013","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15292_bib66","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pvr.2017.06.002","article-title":"HPV vaccination of immunocompromised hosts","volume":"4","author":"Garland","year":"2017","journal-title":"Papillomavirus Res."},{"issue":"8","key":"10.1111\/ajt.15292_bib67","doi-asserted-by":"crossref","first-page":"e015867","DOI":"10.1136\/bmjopen-2017-015867","article-title":"Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of three cohorts from randomized trials","volume":"7","author":"Lehtinen","year":"2017","journal-title":"BMJ Open."},{"issue":"1","key":"10.1111\/ajt.15292_bib68","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ygyno.2017.04.004","article-title":"HPV vaccines \u2013 A review of the first decade","volume":"146","author":"Harper","year":"2017","journal-title":"Gynecol Oncol."},{"issue":"1","key":"10.1111\/ajt.15292_bib69","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/LGT.0000000000000270","article-title":"Improvement of gynecological screening of female renal transplant recipients by self-sampling for human papillomavirus detection","volume":"21","author":"Hinten","year":"2017","journal-title":"J Low Genit Tract Dis."},{"issue":"5","key":"10.1111\/ajt.15292_bib70","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1600-0412.2011.01091.x","article-title":"A systematic review of gynecological cancer surveillance in women belonging to hereditary nonpolyposis colorectal cancer (Lynch syndrome) families","volume":"90","author":"Auranen","year":"2011","journal-title":"Acta Obstet Gynecol Scand."},{"issue":"9609","key":"10.1111\/ajt.15292_bib71","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls","volume":"371","author":"Beral","year":"2008","journal-title":"Lancet."},{"issue":"33","key":"10.1111\/ajt.15292_bib72","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1200\/JCO.2013.48.9021","article-title":"Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis","volume":"31","author":"Moorman","year":"2013","journal-title":"J Clin Oncol."},{"issue":"2","key":"10.1111\/ajt.15292_bib73","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J Natl Cancer Inst."},{"issue":"1","key":"10.1111\/ajt.15292_bib74","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1093\/oxfordjournals.humrep.a136832","article-title":"The CA 125 tumour-associated antigen: a review of the literature","volume":"4","author":"Jacobs","year":"1989","journal-title":"Hum Reprod."},{"issue":"1","key":"10.1111\/ajt.15292_bib75","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2016.05.022","article-title":"Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline","volume":"143","author":"Wright","year":"2016","journal-title":"Gynecol Oncol."},{"issue":"10","key":"10.1111\/ajt.15292_bib76","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S1470-2045(07)70315-7","article-title":"Management of solid tumours in organ-transplant recipients","volume":"8","author":"Ajithkumar","year":"2007","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1111\/ajt.15292_bib77","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/00007890-199408270-00021","article-title":"Salvage of a kidney graft in a patient with advanced carcinoma of the cervix by reimplantation of the graft from the pelvis to the upper abdomen in preparation for radiation therapy","volume":"58","author":"Abouna","year":"1994","journal-title":"Transplantation."},{"issue":"11","key":"10.1111\/ajt.15292_bib78","first-page":"5083","article-title":"Pelvic radiotherapy after renal transplantation","volume":"32","author":"Dahlke","year":"2012","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1111\/ajt.15292_bib79","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4103\/0973-1482.103525","article-title":"Adjuvant pelvic irradiation for cervical cancer in the setting of a transplanted pelvic kidney","volume":"8","author":"Mohiuddin","year":"2012","journal-title":"J Cancer Res Ther."},{"issue":"1","key":"10.1111\/ajt.15292_bib80","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.brachy.2013.11.003","article-title":"Locally advanced cervical cancer in renal transplant patients: a dilemma between control and toxicity","volume":"13","author":"Maroun","year":"2014","journal-title":"Brachytherapy."},{"issue":"3","key":"10.1111\/ajt.15292_bib81","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/1097-0142(19950201)75:3<836::AID-CNCR2820750315>3.0.CO;2-A","article-title":"Ureteral stricture as a late complication of radiotherapy for stage IB carcinoma of the uterine cervix","volume":"75","author":"McLntyre","year":"1995","journal-title":"Cancer."},{"issue":"10","key":"10.1111\/ajt.15292_bib82","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1097\/01.TP.0000137933.97259.E7","article-title":"Three-dimensional conformal radiotherapy for localized prostate cancer in kidney transplant recipients","volume":"78","author":"Mouzin","year":"2004","journal-title":"Transplantation."},{"issue":"9968","key":"10.1111\/ajt.15292_bib83","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(14)61728-1","article-title":"Livebirth after uterus transplantation","volume":"385","author":"Br\u00e4nnstr\u00f6m","year":"2015","journal-title":"Lancet."},{"issue":"7","key":"10.1111\/ajt.15292_bib84","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/aogs.12661","article-title":"The Swedish uterus transplantation project: the story behind the Swedish uterus transplantation project","volume":"94","author":"Brannstrom","year":"2015","journal-title":"Acta Obstet Gynecol Scand."},{"key":"10.1111\/ajt.15292_bib85","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/IJWH.S75635","article-title":"Uterus transplantation: current progress and future prospects","volume":"8","author":"Johannesson","year":"2016","journal-title":"Int J Womens Health."},{"issue":"11","key":"10.1111\/ajt.15292_bib86","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1111\/ajt.14326","article-title":"Living donor uterus transplantation: a single center\u2019s observations and lessons learned from early setbacks to technical success","volume":"17","author":"Testa","year":"2017","journal-title":"Am J Transplant."},{"issue":"1","key":"10.1111\/ajt.15292_bib87","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2016.05.029","article-title":"Immunotherapy for gynecologic cancers","volume":"142","author":"Liao","year":"2016","journal-title":"Gynecol Oncol."},{"issue":"1","key":"10.1111\/ajt.15292_bib88","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ygyno.2015.07.110","article-title":"A population-based case-control study of genetic variation in cytokine genes associated with risk of cervical and vulvar cancers","volume":"139","author":"Hardikar","year":"2015","journal-title":"Gynecol Oncol."},{"issue":"15_suppl","key":"10.1111\/ajt.15292_bib89","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1200\/JCO.2016.34.15_suppl.5515","article-title":"Pembrolizumab in patients with advanced cervical squamous cell cancer: preliminary results from the phase Ib KEYNOTE-28 study","volume":"34","author":"Frenel","year":"2016","journal-title":"J Clin Oncol."},{"issue":"34","key":"10.1111\/ajt.15292_bib90","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1200\/JCO.2015.62.3397","article-title":"Safety and antitumor activity of anti-PD-1 antibody, nivolumab, in patients with platinum-resistant ovarian cancer","volume":"33","author":"Hamanishi","year":"2015","journal-title":"J Clin Oncol."},{"key":"10.1111\/ajt.15292_bib91","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s40425-016-0171-8","article-title":"Antitumor activity of nivolumab on hemodialysis after renal allograft rejection","volume":"4","author":"Ong","year":"2016","journal-title":"J Immunother Cancer."},{"issue":"9","key":"10.1111\/ajt.15292_bib92","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMc1509268","article-title":"Tumor regression and allograft rejection after administration of Anti-PD-1","volume":"374","author":"Lipson","year":"2016","journal-title":"N Engl J Med."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15292","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.15292","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522090621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522090621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15292","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:23:57Z","timestamp":1761629037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522090621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":92,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1600613522090621"],"URL":"https:\/\/doi.org\/10.1111\/ajt.15292","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gynecologic cancers and solid organ transplantation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.15292","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}